Meritage Portfolio Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $572K | Sell |
1,410
-75
| -5% | -$30.4K | 0.04% | 234 |
|
2025
Q1 | $739K | Sell |
1,485
-14
| -0.9% | -$6.97K | 0.05% | 210 |
|
2024
Q4 | $780K | Sell |
1,499
-11
| -0.7% | -$5.72K | 0.05% | 214 |
|
2024
Q3 | $934K | Hold |
1,510
| – | – | 0.06% | 204 |
|
2024
Q2 | $835K | Hold |
1,510
| – | – | 0.05% | 208 |
|
2024
Q1 | $878K | Sell |
1,510
-176
| -10% | -$102K | 0.06% | 205 |
|
2023
Q4 | $895K | Buy |
+1,686
| New | +$895K | 0.06% | 207 |
|
2022
Q1 | – | Sell |
-11,210
| Closed | -$7.48M | – | 381 |
|
2021
Q4 | $7.48M | Buy |
11,210
+118
| +1% | +$78.7K | 0.42% | 62 |
|
2021
Q3 | $6.34M | Buy |
11,092
+122
| +1% | +$69.7K | 0.38% | 69 |
|
2021
Q2 | $5.53M | Buy |
10,970
+292
| +3% | +$147K | 0.33% | 86 |
|
2021
Q1 | $4.87M | Buy |
10,678
+1,888
| +21% | +$862K | 0.32% | 89 |
|
2020
Q4 | $4.09M | Buy |
8,790
+547
| +7% | +$255K | 0.3% | 73 |
|
2020
Q3 | $3.64M | Buy |
8,243
+62
| +0.8% | +$27.4K | 0.33% | 71 |
|
2020
Q2 | $2.96M | Sell |
8,181
-364
| -4% | -$132K | 0.28% | 103 |
|
2020
Q1 | $2.42M | Sell |
8,545
-306
| -3% | -$86.8K | 0.33% | 92 |
|
2019
Q4 | $2.88M | Sell |
8,851
-158
| -2% | -$51.3K | 0.25% | 138 |
|
2019
Q3 | $2.62M | Buy |
9,009
+7,154
| +386% | +$2.08M | 0.25% | 149 |
|
2019
Q2 | $545K | Buy |
+1,855
| New | +$545K | 0.06% | 187 |
|
2013
Q4 | – | Sell |
-76,830
| Closed | -$7.08M | – | 210 |
|
2013
Q3 | $7.08M | Buy |
76,830
+2,970
| +4% | +$274K | 0.92% | 14 |
|
2013
Q2 | $6.25M | Buy |
+73,860
| New | +$6.25M | 0.9% | 16 |
|